Correction: Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers
Crossref DOI link: https://doi.org/10.1007/s40262-024-01378-z
Published Online: 2024-05-02
Published Print: 2024-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bevers, Lisanne A. H. https://orcid.org/0009-0004-3699-2993
Kamphuis, Anne E. M.
van der Wekken-Pas, L. C. Wendy
Leisegang, Rory
Burger, David M.
Colbers, Angela
Text and Data Mining valid from 2024-05-01
Version of Record valid from 2024-05-02
Article History
First Online: 2 May 2024